FrançaisNovacyt Group, an international specialist in cancer and infectious diseases, has diversified sales from diagnostic products used in LBC, oncology, microbiology, haematology and serology testing. We support a large global customer base which includes hospitals to large corporates.
Microbiology
Microgen Bioproducts develop, manufacture and distribute high quality diagnostic products for clinical and food laboratories.
Haematology & Serology Products
Lab21 Healthcare manufactures and supplies an extensive range of reagents and tests for IVD application and blood grouping.
Novacyt Group History
Novacyt has noticeably evolved since the acquisition of Lab 21 in June 2014.
2005
Inception of Lab 21 (Microgen, Biotec, Plasmatec and Lab 21)
2006
Inception of Novacyt SA
2008
Initial commercial launch of NOVAPREP®
2012
Listing of Novacyt on Alternext Paris
2014
Acquisition of Lab 21
2016
Acquisition of Primer Design
2017
Admission onto AIM London Stock Market
2019
Sale of Lab21 Clinical Lab
2020
Sale of NOVAprep
2020
Worlds first CE-IVD COVID-19 kits
2020
Acquisition of IT-IS International Ltd.
Quality Policy
Within the Novacyt Group, we are committed to Quality as a fundamental part of all its business activities and strives to meet and exceed external and internal customer expectations. As a learning organisation we will continuously drive innovation, improvements and excellence for all our products and services whilst meeting all regulatory requirements for the markets we serve.
To support this, we have established this Quality Policy and have the following Quality Objectives:
To implement and maintain a Quality Management System that complies with the requirements laid down in the IVD Directive (98/79/EC), EN ISO 13485:2012 and other regulations as required to support business activities
To monitor and measure the performance of both the products we sell, and the systems and processes we operate to identify and implement continuous improvements
To ensure that the importance of Quality is communicated to all employees throughout the business through regular information updates, and that employees are trained and supported to deliver good products and services
To involve all employees in owning and improving the Quality Management System to the benefit of customers, employees and other stakeholder groups
To place Quality as a fundamental cornerstone of annual business strategic planning
This Quality Policy will be reviewed annually for continuing suitability.